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Abstract
Background:  The aim of this study was to evaluate the diagnostic potential of
immunohistochemistry using an antibody to the secreted mycobacterial antigen MPT64, in
abdominal and lymph node tuberculosis.
Methods: We used formalin-fixed histologically diagnosed abdominal tuberculosis (n = 33) and
cervical tuberculous lymphadenitis (n = 120) biopsies. These were investigated using a combination
of Ziehl-Neelsen method, culture, immunohistochemistry with an antibody to MPT64, a specific
antigen for Mycobacterium tuberculosis complex organisms. Abdominal and cervical lymph node
biopsies from non-mycobacterial diseases (n = 50) were similarly tested as negative controls.
Immunohistochemistry with commercially available anti-BCG and nested PCR for IS6110 were
done for comparison. Nested PCR was positive in 86.3% cases and the results of all the tests were
compared using nested PCR as the gold standard.
Results: In lymph node biopsies, immunohistochemistry with anti-MPT64 was positive in 96 (80%)
cases and 4 (12.5%) controls and with anti-BCG 92 (76.6%), and 9 (28%) respectively. The results
for cases and controls in abdominal biopsies were 25 (75.7%) and 2 (11.1%) for anti-MPT64 and 25
(75.7%) and 4 (22%) for anti-BCG. The overall sensitivity, specificity, positive and negative
predictive values of immunohistochemistry with anti-MPT64 was 92%, 97%, 98%, and 85%,
respectively while the corresponding values for anti-BCG were 88%, 85%, 92%, and 78%.
Conclusion: Immunohistochemistry using anti-MPT64 is a simple and sensitive technique for
establishing an early and specific diagnosis of M. tuberculosis infection and one that can easily be
incorporated into routine histopathology laboratories.
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Background
Extra-pulmonary tuberculosis (EPTB) accounts for
approximately 10–15% of all tuberculosis infections and
occurs in up to 50% of patients with human immunode-
ficiency virus (HIV)-tuberculosis co-infection [1-3]. The
annual incidence rates of EPTB have increased not only in
developing countries but globally over the last few years
[1,2,4].
The diagnosis of EPTB has always been problematical.
Clinically, the disease presents in protean ways and histo-
logical examination is usually required for the diagnosis.
Due to overlap of the histological features with other
granulomatous conditions, the diagnosis of tuberculosis
is dependent on the demonstration of acid fast bacilli
(AFB) by Ziehl-Neelsen (ZN) staining. The yield of this
method is limited however, in paucibacillary EPTB [5-7]
and fresh unfixed tissue with live bacilli is usually not
available for culture. Moreover, culture takes several
weeks and is often negative in EPTB. There is therefore, a
great need for a better diagnostic test to provide an alter-
native to AFB microscopy and culture.
While,  Mycobacterium tuberculosis is the most common
causative agent of EPTB, the prevalence of non-tubercu-
lous mycobacteria is increasing with or without HIV infec-
tion and ranges from 3.8 to 50% in different parts of
world [7-9]. As treatment is different for the two condi-
tions, it is important to make a definitive diagnosis. How-
ever, in areas of the world where the disease is endemic,
less than half receives an accurate diagnosis leading to
inappropriate empirical treatment [10-12].
Detection of mycobacterial antigens by immunohisto-
chemistry (IHC) using polyclonal and monoclonal anti-
bodies is an alternative to conventional acid-fast staining.
A large number of different mycobacterial antigens
including BCG, lipoarabinomannan [5,13-17] have been
detected with varying results in tissues. These are all com-
mon mycobacterial antigens and thus cannot discrimi-
nate M. tuberculosis from non-tuberculous mycobacteria.
However, in a pilot study, we have recently described the
high sensitivity and specificity of an in-house rabbit poly-
clonal antibody in biopsies from patients with tubercu-
lous lymphadenitis to detect a secretory mycobacterial
antigen, MPT64, which is present only in M. tuberculosis
complex [14,18].
The present study was undertaken to further evaluate the
diagnostic potential of immunohistochemial staining to
detect MPT64 using a larger sample size from a different
population and including other sites. Formalin fixed par-
affin embedded biopsies from patients with abdominal
tuberculosis and tuberculous lympadenitis were exam-
ined and the performance of anti-MPT64 was compared
with the commercially available anti-BCG.
Methods
Histologically diagnosed abdominal tuberculosis (n = 33)
and cervical tuberculous lymphadenitis (n = 120) biop-
sies were obtained from the Department of Pathology,
Ujjain Hospital, Ujjain, India between July 2004 to March
2006. The diagnostic categories included in the study for
cases and controls are shown in table 1. Control biopsies
were obtained from the Ujjain Hospital, and also the
Department of Pathology, Haukeland University Hospi-
tal, Bergen, Norway. Two pulmonary tuberculosis biopsy
specimens from the archive with numerous AFB on ZN
staining were used as known positive control when
required.
Biopsies from patients with pulmonary tuberculosis, on
corticosteroids, immunosuppressive therapy were
excluded from the study. Detailed clinical history and
Table 1: Diagnostic categories of specimens tested.
Diagnosis Cervical Lymph Nodes Intestinal wall Peritoneum Mesentric Lymph Nodes* Total number of specimens
CASES
Tuberculosis 120 19 9 5 153
NEGATIVE CONTROLS
Reactive/Non Specific inflammation 16 0 1 13 30
Foreign body granuloma# 10 0 0 0 10
Fungal granuloma 4 0 0 0 4
Parasitic granuloma 0 3 0 0 3
Malignancy 2 0 1 0 3
TOTAL 152 22 11 18 203
* no associated intestinal lesion seen.
# all foreign body granuloma were in skin biopsies.Diagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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examination results were obtained either from the clinical
records or from the patients. The majority of lymphaden-
itis patients presented with a neck mass, while abdominal
tuberculosis was mainly associated with abdominal pain.
Informed written consent was obtained and the patients
were ensured of confidentiality. Ethical approval was
obtained from the Institutional ethical committee at
Ujjain Hospital and the regional ethical committees in
both Norway and India. All the patients were tested for
HIV.
Culture, ZN staining & Histopathology
One-half of the fresh biopsy specimens were submitted
for mycobacterial culture on Lowenstein-Jensen egg
media. The other half of the biopsy was fixed by 4% phos-
phate buffered formaldehyde for conventional paraffin
embedding followed by routine haematoxylin and eosin
and ZN stain to detect AFB. ZN staining was performed by
heat carbol fuchsin method.
For histopathology, the sections were examined for the
presence of granulomas and subdivided into two groups
for analysis. Well-organized granulomas were character-
ized by a central group of epitheloid histiocytes, Lang-
han's giant cells, a mantle of lymphocytes and fibrous
tissue. Poorly-organized granulomas showed a diffuse
mixture of lymphocytes, histiocytes, and plasma cells with
occasional giant cells. Each granuloma was also analyzed
for the presence or absence of necrosis. The number of
granulomas per sections, their type of organization and
presence of necrosis was noted.
Immunohistochemistry
IHC was performed using the DakoCytomation kit (EnVi-
sion + System-HRP; DakoCytomation Denmark A/S,
Glostrup, Denmark). Tissue sections were deparaffinized,
hydrated, and after microwave antigen retrieval, the
endogenous peroxidase activity was inhibited by incubat-
ing the sections with hydrogen peroxide for 8 minutes.
The slides were then treated with primary antibodies – (i)
anti-BCG, (DAKO, Hamburg, Germany) at 1/5000 dilu-
tion for 1 hour after treating sections with 3% bovine
serum albumin for 3 minutes, (ii) in-house absorbed pol-
yclonal anti-MPT64 antibody at 1/250 dilution for 1
hour. Optimal dilutions were determined prior to these
experiments. Sections were incubated with anti-rabbit
dextran polymer conjugated to horseradish peroxidase for
45 minutes (30 minutes for anti-BCG). Antigen was visu-
alized with 3-amino-9-ethylcarbazol- and hydrogen per-
oxide containing substrate and counter-stained with
haematoxylin. All incubations were carried out at room
temperature and the sections were thoroughly washed in-
between incubations. In every experiment, one positive
control and two negative controls were included. In one
negative control primary antibody was substituted with
antibody diluent and the other was with an irrelevant rab-
bit polyclonal antibody.
Mycobacterial antigen load was evaluated by counting the
stained cells with light microscopy using a 40× ocular fit-
ted with a 10 × 10 mm graticule and by evaluation of the
staining intensity. For each section, three granulomas
were selected for analysis. The number of stained epith-
eloid cells, stained giant cells and the total number of
nucleated cells were counted for each granuloma and the
results were presented as percentage of stained cells. The
intensity of staining of section was evaluated separately
and categorized as weak, moderate, and strong staining
based on subjective assessment.
Nested Polymerase Chain Reaction for IS6110
Five to six, 8 µm sections from each paraffin embedded
tissue blocks were collected in sample preparation tubes
for nested PCR. Carry-over tissue contamination was pre-
vented by cleaning the blade with 96% ethanol after sec-
tioning each sample; negative controls were sectioned
first, followed by test blocks and positive control blocks.
DNA extraction and nested PCR on paraffin sections were
performed as described previously [14]. Briefly, following
proteinase K digestion, bacterial genomic DNA was eluted
in water using a MagAttract DNA mini M48 Kit (Qiagen,
West Sussex, UK) on Biorobot M48 (Qiagen). A 123-base
pair fragment from IS6110 was amplified using the fol-
lowing primers 5' CCTGCGAGCGTAGGCGTCGG 3' and
5' CTCGTCCAGCGCCGCTTCGG 3'. The product was
subjected to a second round of PCR amplification using
the primers 5' TTCGGACCACCAGCACCTAA 3' and 5'
TCGGTGACAAAGGCCACGTA 3' to amplify a 92-base
pair fragment. The PCR reaction mixture consisted of 5 µl
eluted DNA, 25 µl of HotStarTaq master mix (Qiagen),
0.25 µl of each 100 µM primer stock solution, distilled
water to make a final volume of 50 µl. For nested PCR, 1
µl of the first PCR product was used as template. The reac-
tion cycle for the first PCR was – 94°C for 1 minute, 68°C
for 1 minute, 72°C for 20 seconds for 45 cycles and for the
nested PCR – 94°C for 1 minute, 58°C for 1 minute,
72°C for 20 seconds for 35 cycles. Both PCR's had an ini-
tial heat activation step of 95°C for 15 minutes and a final
extension of 72°C for 10 minutes. The amplified product
was analyzed in a 3% agarose gel stained with ethidium
bromide. Mycobacterial DNA, and positive PCR product
were included as positive controls and an extraction con-
trol (with all the steps but without any tissue), a reaction
tube with substitution of distilled water for the test tem-
plate and a sample which previously yielded negative
result on PCR were included as negative control in each
PCR run.Diagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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Data Analysis
Data entry and analysis was done using SPSS 12.0 for
Windows. Pearsons chi-square test was used to determine
the significance among categorical variables. Non-para-
metric tests were used for two-group comparisons. Differ-
ences were considered statistically significant if p ≤ 0.05.
The diagnostic indices were calculated by decision matrix
comparison.
Results
A total of 203 biopsy specimens were studied. All the
patients were negative for HIV.
Acid-Fast Bacilli microscopy and Culture (table 2)
Acid fast bacilli were detected by ZN staining of abdomi-
nal and lymph node biopsies in 0/33 (0%) and 14/120
(11.7%) specimens respectively. Mycobacterium was iso-
lated on culture from 4/33 (12.1%) and 27/117 (23%)
specimens of abdominal and lymph node cases respec-
tively. Culture results were not available from 3 cases and
24 controls. None of the control biopsies showed positive
result for either of the tests.
Histopathology
Both well-organized and poorly-organized granulomas
were observed in biopsies from abdominal and lymph
node cases. In abdominal tuberculosis, all the mesenteric
lymph nodes showed well-organized necrotic granulomas
and in intestinal wall, necrotic granulomas were seen in
58% of the cases while other cases had non-necrotic gran-
ulomas with or without fibrosis.
Lymph nodes showed typical well-organized granulomas
in 70% of cases, mixed in 18% and poorly-organized in
12% of cases. Ninety percent of cases showed necrosis,
however, both necrotic and non-necrotic granulomas
were often seen in the same section.
Immunohistochemistry
IHC with anti-MPT64 was positive in 14 (73.7%), 7
(77.7%) and 4 (80%) cases from intestinal wall, perito-
neum, and mesenteric lymph node respectively and 2
(11%) controls. Similarly, the corresponding results for
anti-BCG were 15 (78.9%), 6 (66%), 4 (80%) respectively
for cases and 4 (22%) for controls (Table 2). In lymph
node biopsies, IHC with anti-MPT64 was positive in 96
(80%) cases and 4 (12.5%) controls whereas anti-BCG
was positive in 92 (76.6%) cases, and 9 (28.1%) controls.
A comparison of the two antibodies looking at percentage
of stained cells, and intensity of staining in relation to
necrosis and organization of granulomas is shown in
table 3 and figures 1 and 2. In the well-organized granulo-
mas, the percentage of stained cells (p = 0·04) and the
intensity of staining (+2 or +3; p = 0.001) was significantly
higher for anti-MPT64 than anti-BCG. No significant dif-
ference of staining percentage or intensity was detected
between the two antibodies in poorly-organized granulo-
mas. In non-necrotic granuloma the percentage of posi-
tive cells (p = 0.02) and the intensity of staining (p = 0.03)
was significantly higher with anti-MPT64 than with anti-
BCG. In the necrotic granulomas, the intensity of staining
with anti-MPT64 was higher but there was no significant
difference between the percentages of stained cells
between the two antibodies.
The location and pattern of expression of the two antibod-
ies varied. Staining with anti-MPT64 was seen mainly in
the inflammatory cells. The necrotic centres were gener-
ally negative, except in 8% of necrotic granulomas where
occasional but strong signals were detected. Staining pat-
tern was predominantly granular with anti-MPT64. With
anti-BCG, positive signals were detected both in the
necrotic centre and in inflammatory cells in all the
necrotic granulomas. Unlike anti-MPT64, the staining
pattern with anti-BCG was predominantly diffuse (fig. 2,
3).
Table 2: Positive results of different diagnostic procedure on cervical lymph nodes and abdominal biopsies.
Diagnostic Procedure Cervical Lymph Nodes Biopsy 
(n = 152)
Abdominal biopsy (n = 51)

























ZN stain 14(11.6) 0 0 0 0 0 0 0
LJ Culture 27(22.5) 0 0 0 2(22) 0 2(40) 0
Anti-BCG 92(76.6) 9(28) 15(78.9) 1(33) 6(66) 1(50) 4(80) 2(15.4)
Anti-MPT64 96(80) 4(12.5) 14(73.7) 0 7(77.7) 1(50) 4(80) 1(7.7)
PCR 104(86.6) 3(9.4) 17(89) 0 7(77.7) 0 4(80) 1(7.7)Diagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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The performance of the two antibodies in giant cells was
assessed separately. Unlike the epithelioid cells, there was
no significant difference in the percentage of giant cells
stained with either of the antibodies. However, the inten-
sity of staining for anti-BCG in the giant cells was weak
compared to anti-MPT64 (fig. 2C, 2F).
Polymerase Chain Reaction
The results of IS6110 PCR assay is shown in table 2. Over-
all PCR assay positivity was 132/153(86.6%) in histolog-
cally diagnosed tuberculosis cases. Among these, eight
cases were positive after the first PCR amplification while
the majority (n = 124) were positive on nested PCR only.
Cases which were positive with first PCR run had higher
percentage of anti-MPT64 stained cells. All the positive
controls were positive on both first PCR run and nested
PCR.
Comparison and validation of the result of various tests
The results of various tests were compared using nested
PCR as the gold standard. All ZN and culture positive
cases were positive for anti-MPT64, anti-BCG and PCR
while ZN was positive in only 14 culture positive cases.
With IHC using anti-MPT64 and anti-BCG positive results
Table 3: Intensity of immunohistochemical staining by two antibodies in relation to granuloma features.
Granuloma characteristics Intensity of anti-BCG staining Intensity of anti-MPT64 staining
Mild Moderate Strong Mild Moderate Strong
Organization
Well Organised 46* 38 9 8 51** 34
Non Organised 28 8 1 13 14 10
Necrosis
Non Necrotic 30 23 4 4 29 24
Necrotic 44 23 6 17 36*** 20
*p = .02, **p = .001, ***p = .026
A: Percentage of stained cells by two antibodies in relation to organization of granuloma Figure 1
A: Percentage of stained cells by two antibodies in relation to organization of granuloma. B: Percentage of stained cells by two 
antibodies in relation to necrosis in granuloma.Diagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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were found in125 and 120 specimens respectively with a
sensitivity of more than 85% by both antibodies (table 4).
Of 67 PCR negative cases, anti-MPT64 and anti-BCG were
negative in 65 and 57 respectively, thus giving a specificity
of 93% for anti-MPT64 and 88% for anti-BCG (table 4).
Overall comparison showed significant differences in the
sensitivity of IHC compared with sensitivity of ZN stain-
ing and culture (p =< 0.001). No significant difference was
found in the specificity of IHC when compared with the
other tests. The proportion agreement between PCR and
anti-MPT64 was 93% (kappa-0.85).
Comparison between Cervical Lymph Node and 
Abdominal Tissue Samples for various tests
In tuberculous lymphadenitis the sensitivity of ZN stain-
ing (13%) and culture (25%) was higher than in abdom-
inal tuberculosis (0% and 12.5% respectively). The
sensitivity of IHC with both the antibodies was high and
there was no significant difference between cervical tuber-
culous lymph nodes and different sites of abdominal
tuberculosis. The specificity of anti-BCG was, however,
60% in intestinal wall compared to 86% and 92.3% in
cervical lymph nodes and mesenteric lymph nodes respec-
tively. In contrast, specificity with MPT64 was very high
and was found to be 100% in intestinal wall and
mesenteric lymph nodes and 98% in cervical lymph
nodes (table 4).
Immunohistochemical staining in abdominal tuberculosis Figure 2
Immunohistochemical staining in abdominal tuberculosis. A-C : Staining by anti-BCG in granuloma in intestinal wall, 
D-F : staining by anti-MPT64 in granuloma in intestinal wall. The area in square is magnified in subsequent sections, G : staining 
by anti-BCG in granuloma in peritoneum, H : diffuse staining of giant cells in peritoneum by anti-BCG, I : same giant cell as 
shown in H showing strong, granular staining with anti-MPT64.Diagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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Discussion
There have been several reports describing the use of IHC
in the diagnosis of tuberculosis (14). However, in this
study we show that using an antigen against the secretory
mycobacterial antigen MPT64, it is possible to achieve
consistently high sensitivity (89-93%) and specificity (95-
98%) with IHC on different types of tissues. The strength
of this technology is that it is robust, readily available in
routine surgical pathology laboratories and can detect
fragmented tubercle bacilli [19]. Compared with ZN
staining that has a sensitivity of 10–45% [19] and requires
an intact cell wall this technique offers a major improve-
ment in diagnostic potential and should be suited for the
diagnosis of pauci-bacillary EPTB. IHC for tuberculosis
has, however, been slow to catch on as a routine diagnos-
tic method in histopathology laboratories probably due
to the lack of a specific anti-mycobacterial antibody suita-
ble for all types of tissue [5,14,16] and hence the exact
diagnostic role of IHC for M. tuberculosis has to be assessed
in appropriate control groups and with appropriate antis-
era in endemic areas. Our large study is the first to show
that IHC with an antibody to MPT64 is sufficiently robust
Immunohistocheminal staining of lymph node tuberculosis Figure 3
Immunohistocheminal staining of lymph node tuberculosis. A : Staining by anti-BCG in organized granuloma. The cen-
tral necrotic area is also showing staining, B : staining by anti-BCG in poorly organized granuloma. There is diffuse staining with 
background staining, C : The diffuse and weak staining of giant cell by anti-BCG, D : staining by anti-MPT64 in organized granu-
loma. The central necrotic area is not showing staining, E : staining by anti-MPT64 in poorly organized granuloma. There is 
granular staining in clear background, F : The strong and granular staining of giant cell by anti-MPT64.Diagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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to establish etiological diagnosis of M. tuberculosis complex
infection in different types of tissues of EPTB.
Our results show that IHC with anti-MPT64 has better
specificity, sensitivity, and predictive values than anti-
BCG (table 4). This was particularly clear in intestinal wall
tuberculosis, where anti-MPT64 showed a 100% specifi-
city compared with 60% for anti-BCG (table 3). Anti-
MPT64 antibodies also gave sharp and strong signals with
clear background compared with anti-BCG antibodies
making interpretation easier and permitting a more confi-
dent diagnosis of M. tuberculosis complex organism. Lower
specificity with anti-BCG could be due to cross-reactivity
with other infectious organisms as described earlier [20-
22].
The sensitivity of anti-MPT64 is also very high but not very
different from anti-BCG. The amplification method used
in IHC improves the recognition of positive fragments.
The few false negatives could be caused by the length of
formalin fixation prior to processing which is known to
reduce sensitivity[23]. Another explanation for the false
negative results may be that the number of mycobacteria
present is below the sensitivity level of IHC (about 5 × 105
to 1 × 106 organisms per gram tissue) and the lesions are
exuberant inflammatory responses to a minimal number
of organisms[24].
Four of the negative controls were positive with both PCR
and IHC with both antibodies. Among these were two
lymph node samples with histological changes of non-
specific lymphadenitis that may represent early or latent
tuberculosis infection. According to Goel et al [25], early
tuberculous lesions may not be identified by histopathol-
ogy because the formation of granulomas and emergence
of the classical histopathological tuberculous picture may
be a late phenomenon. They suggest that such cases might
represent the transition between the incubation and
development of disease[25]. Perhaps, in some cases, our
IHC method can play a role in the early diagnosis of tuber-
culosis when histological examination fails to provide a
diagnosis. The high prevalence of tuberculosis together
with parasitic infection is well known in tuberculosis
endemic countries. One of our controls with intestinal
parasite turned out positive with IHC and PCR [26] and
may well be a case of tuberculosis. It is difficult to explain
the positive results of both tests on foreign body granulo-
mas from Norway, however, as suggested by Mustafa et al,
the possibility of latent infection cannot be ruled out [14].
In endemic countries, the majority of granulomatous
lesions without necrosis are considered to be tuberculosis
but this may not be the case in the developed world. Inter-
estingly, when we looked specifically for the bacilli in the
different zones of the granuloma they were more fre-
quently detected by anti-MPT64 in the epitheloid cells
than in the necrotic area. Using anti-BCG antibodies anti-
gens were also detected in necrotic area. We also found
that the percentage of stained cells was higher in non-
necrotic granulomas than in necrotic granuloma with
anti-MPT64 compared to anti-BCG with clearer and
stronger signals. Hence, non-necrotic granulomatous
lesion staining with MPT64 will support a diagnosis of
tuberculosis.
Ideally, culture should be used as gold standard when
comparing diagnostic test performance in tuberculosis.
This investigation is, however, associated with low sensi-
tivity especially in EPTB and as in our series, the corre-
sponding results from controls are usually not available
[27]. Histopathology remains one of the most important
methods for diagnosing tuberculosis, however; it cannot
differentiate changes caused by M. tuberculosis, non-tuber-
culous mycobacteria or other granulomatous diseases. We
used nested PCR as the reference for comparison. In recent
years, the sensitivity and specificity of PCR for diagnosis of
tuberculosis has been well documented and is in the range
of 60–98% in reported series where PCR was compared
with culture as gold standard [28,29]. Our results also
showed strong association between PCR and culture with
all culture positive samples also being PCR positive. While
PCR is increasingly used in the detection of mycobacteria
from the tissue sample, the cost of the instruments and
reagents, sensitivity to contamination and technical
demand limits its use in developing countries [30].
Conclusion
We have shown that IHC with an antibody to MPT64, a
secreted antigen specific to the M. tuberculosis complex, is
a specific and sensitive technique for diagnosis of EPTB. It
is a cheap, robust and rapid method that can be used in a
routine laboratory to provide a result in one working day
and ensures the early institution of therapy. Being specific,
Table 4: Diagnostic validation of different tests using nested PCR 
as gold standard (all values are in percentage).
Diagnostic method Sensitivity Specificity PPV NPV
LYMPH GLAND TB
Anti-BCG 88 86 94 76
Anti-MPT64 93 98 99 85
ABDOMINAL TB
Anti-BCG 86 81 86 81
Anti-MPT64 89 95 96 87
TOTAL TB CASES
Anti-BCG 88 85 92 78
Anti-MPT64 92 97 98 85
PPV = positive predictive value, NPV = negative predictive valueDiagnostic Pathology 2007, 2:36 http://www.diagnosticpathology.org/content/2/1/36
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anti-MPT64 would be of value in differentiating M. tuber-
culosis from other organisms, especially non-tuberculous
mycobacteria, and other granulomatous inflammations.
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